GlassScriptPhysician profile
Soliman M Soliman
NPI 1164591947
$2,781.44
in general payments reported to CMS, 2019-2025
22 companies · $68.62 in 2025
The $68.62 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $306 · 2021: $539 · 2022: $892 · 2023: $637 · 2024: $164 · 2025: $68.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $592.71 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Medical Device Business Services, INC. | $445.71 | 2022 | |
| Abbott Laboratories | $354.47 | 2019-2025 | Ensite Precision, Merlin@Home, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $289.77 | 2019-2024 | Lifevest |
| Pfizer INC. | $270.35 | 2019-2022 | |
| Boston Scientific Corporation | $222.79 | 2021-2024 | Watchman Access System |
| Biotronik INC. | $145.74 | 2023 | Biomonitor, Edora 8 Dr-T |
| Cardiva Medical, INC. | $93.69 | 2021 | |
| Livanova USA, INC. | $88.85 | 2022 | |
| Edwards Lifesciences Corporation | $42.05 | 2023 | Hemosphere |
| E.R. Squibb & Sons, L.L.C. | $41.57 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $32.29 | 2021-2022 | |
| Amgen INC. | $27.81 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $27.48 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $23.24 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $19.72 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.93 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.17 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.93 | 2019 | |
| Preventice Services, LLC | $11.64 | 2021 | |
| Bardy Diagnostics, INC. | $11.53 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soliman Soliman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.